Evaxion AS (EVAX)

2.98 -0.02 (-0.67%) USD  |  NASDAQ  |  Sep 01, 16:00
2.99 +0.01 (+0.34%) After-Hours: 20:00
More

Evaxion Cash from Operations (Annual) : -6.645M for Dec. 31, 2025

Cash from Operations (Annual) Chart

View Cash from Operations (Annual) for EVAX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Annual) Chart
Start Trial

Historical Cash from Operations (Annual) Data

View and export this data back to 2018. Start Trial.
Date Value
December 31, 2025 -6.645M
December 31, 2024 -12.92M
December 31, 2023 -17.72M
December 31, 2022 -25.79M
Date Value
December 31, 2021 -21.90M
December 31, 2020 -12.52M
December 31, 2019 -7.025M
December 31, 2018 -1.976M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Annual) Range, Past 5 Years

View Cash from Operations (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Annual) Benchmarks

View Cash from Operations (Annual) Benchmarks
Start Trial
Autolus Therapeutics Plc -284.23M
Cellectis SA -40.14M
Akari Therapeutics Plc -10.59M
DBV Technologies SA -121.56M
argenx SE 850.49M